Halberstadt AL - Search Results

1

The selective 5-HT_2A receptor agonist 25CN-NBOH: Structure-activity relationship, in vivo pharmacology, and in vitro and ex vivo binding characteristics of [³H]25CN-NBOH.

Jensen AA, Halberstadt AL, Märcher-Rørsted E, Odland AU, Chatha M, Speth N, Liebscher G, Hansen M, Bräuner-Osborne H, Palner M, Andreasen JT, Kristensen JL. Jensen AA, et al. Among authors: halberstadt al. Biochem Pharmacol. 2020 Jul;177:113979. doi: 10.1016/j.bcp.2020.113979. Epub 2020 Apr 13. Biochem Pharmacol. 2020. PMID: 32298690

2

Interactive effects of mGlu5 and 5-HT2A receptors on locomotor activity in mice.

Halberstadt AL, Lehmann-Masten VD, Geyer MA, Powell SB. Halberstadt AL, et al. Psychopharmacology (Berl). 2011 May;215(1):81-92. doi: 10.1007/s00213-010-2115-1. Epub 2010 Dec 10. Psychopharmacology (Berl). 2011. PMID: 21153406 Free PMC article.

3

Effects of the hallucinogen 2,5-dimethoxy-4-iodophenethylamine (2C-I) and superpotent N-benzyl derivatives on the head twitch response.

Halberstadt AL, Geyer MA. Halberstadt AL, et al. Neuropharmacology. 2014 Feb;77:200-7. doi: 10.1016/j.neuropharm.2013.08.025. Epub 2013 Sep 4. Neuropharmacology. 2014. PMID: 24012658 Free PMC article.

4

Effect of 5-HT2A and 5-HT2C receptors on temporal discrimination by mice.

Halberstadt AL, Sindhunata IS, Scheffers K, Flynn AD, Sharp RF, Geyer MA, Young JW. Halberstadt AL, et al. Neuropharmacology. 2016 Aug;107:364-375. doi: 10.1016/j.neuropharm.2016.03.038. Epub 2016 Mar 25. Neuropharmacology. 2016. PMID: 27020041 Free PMC article.

5

Effect of Hallucinogens on Unconditioned Behavior.

Halberstadt AL, Geyer MA. Halberstadt AL, et al. Curr Top Behav Neurosci. 2018;36:159-199. doi: 10.1007/7854_2016_466. Curr Top Behav Neurosci. 2018. PMID: 28224459 Free PMC article. Review.

6

Receptor binding profiles and behavioral pharmacology of ring-substituted N,N-diallyltryptamine analogs.

Klein LM, Cozzi NV, Daley PF, Brandt SD, Halberstadt AL. Klein LM, et al. Among authors: halberstadt al. Neuropharmacology. 2018 Nov;142:231-239. doi: 10.1016/j.neuropharm.2018.02.028. Epub 2018 Feb 27. Neuropharmacology. 2018. PMID: 29499272 Free PMC article.

7

Pharmacological characterization of the LSD analog N-ethyl-N-cyclopropyl lysergamide (ECPLA).

Halberstadt AL, Klein LM, Chatha M, Valenzuela LB, Stratford A, Wallach J, Nichols DE, Brandt SD. Halberstadt AL, et al. Psychopharmacology (Berl). 2019 Feb;236(2):799-808. doi: 10.1007/s00213-018-5055-9. Epub 2018 Oct 8. Psychopharmacology (Berl). 2019. PMID: 30298278 Free PMC article.

8

Comparison of the behavioral responses induced by phenylalkylamine hallucinogens and their tetrahydrobenzodifuran ("FLY") and benzodifuran ("DragonFLY") analogs.

Halberstadt AL, Chatha M, Stratford A, Grill M, Brandt SD. Halberstadt AL, et al. Neuropharmacology. 2019 Jan;144:368-376. doi: 10.1016/j.neuropharm.2018.10.037. Epub 2018 Oct 29. Neuropharmacology. 2019. PMID: 30385253 Free PMC article.

9

Correction to: Pharmacological characterization of the LSD analog N-ethyl-N-cyclopropyl lysergamide (ECPLA).

Halberstadt AL, Klein LM, Chatha M, Valenzuela LB, Stratford A, Wallach J, Nichols DE, Brandt SD. Halberstadt AL, et al. Psychopharmacology (Berl). 2019 Feb;236(2):809. doi: 10.1007/s00213-018-5117-z. Psychopharmacology (Berl). 2019. PMID: 30443792

10

Chronic treatment with a metabotropic mGlu2/3 receptor agonist diminishes behavioral response to a phenethylamine hallucinogen.

Halberstadt AL, van der Zee JVF, Chatha M, Geyer MA, Powell SB. Halberstadt AL, et al. Psychopharmacology (Berl). 2019 Feb;236(2):821-830. doi: 10.1007/s00213-018-5118-y. Epub 2018 Nov 17. Psychopharmacology (Berl). 2019. PMID: 30448990 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

88 results

Search Page